Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Grant or award Director acquired 9,000 shares (grant or award)
  2. 4 Grant or award Director acquired 9,000 shares (grant or award)
  3. 4 Planned sale CFO and CBO sold 2,110 shares at $12.87 ($27,165)
  4. 4 Open-market buy Director bought 1,000 shares at $7.55 ($7,550)
  5. 4 Open-market buy Chief Operating Officer bought 10,000 shares at $8.26 ($82,600)
  6. 4 Open-market buy President and Chief Executive bought 12,919 shares at $7.82 ($101,025)
  7. 4 Planned sale CFO and CBO sold 3,439 shares at $7.27 ($25,002)
  8. 4 Open-market sale CFO and CBO sold 2,032 shares at $8.53 ($17,335)
  9. 4 Open-market sale President and Chief Executive sold 1,436 shares at $8.54 ($12,265)
  10. 4 Open-market buy Director bought 5,000 shares at $7.73 ($38,660)
  11. 4 Open-market sale President and Chief Executive sold 5,821 shares at $8.20 ($47,729)
  12. 4 Grant or award Chief Operating Officer acquired 45,000 shares (grant or award)
  13. 4 Grant or award CFO and CBO acquired 33,000 shares (grant or award)
  14. 4 Open-market buy Director bought 5,000 shares at $7.00 ($35,000)
  15. 4 Open-market sale CFO and CBO sold 2,159 shares at $9.60 ($20,726)
  16. 4 Open-market sale President and Chief Executive sold 1,526 shares at $9.60 ($14,650)
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award President and Chief Executive acquired 7,500 shares (grant or award)
  19. 4 Grant or award Chief Operating Officer acquired 7,500 shares (grant or award)
  20. 4 Grant or award CFO and CBO acquired 7,500 shares (grant or award)

Page 6 of 12 · 224 filings